TIP25-243: Randomized Study Evaluating Optimal Dose, Efficacy and Safety of E7386 + Lenvatinib Versus Treatment of Physicians' Choice in Advance/Recurrent Endometrial Carcinoma Previously Treated With Anti-PD-(L)1 Immunotherapy.
Journal: Journal Of The National Comprehensive Cancer Network : JNCCN
Published:
Authors
Ramez Eskander, Jung-yun Lee, Mansoor Mirza, Domenica Lorusso, Helen Mackay, Isabelle Ray Coquard, Ana Oaknin, Antonio Gonzalez Martin, Kosei Hasegawa, Bradley Corr, Xiaohua Wu, Alexandra Leary, Tianle Hu, Lea Dutta, Chinyere Okpara, Jodi Mckenzie, Vicky Makker
Relevant Conditions